up-arrow
arrow_back

DSP Healthcare Fund

DSP Healthcare Fund

share icon

Benchmark: BSE HEALTHCARE (TRI) info icon

1.7 lakh people have invested in this fund

View performance details

Return:

This fund

18.00%

BSE HEALTHCARE (TRI)

14.30%

NIFTY 50 TRI

14.15%

Invested

Earning

This fund

18.00%

BSE HEALTHCARE (TRI)

14.30%

NIFTY 50 TRI

14.15%

team 1.7 lakh people have invested in this fund as of

This is an Equity Sectoral/Thematic, Pharma fund with BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk.

Total AUM

3,138.46 crores as of Oct 31, 2024

Age of Fund

5 years 11 months since Nov 30, 2018

Expense Ratio

1.92% as of Nov 08, 2024

Exit Load

0.5% If redeemed between 0 - 1 Months

Ideal holding period

10 Years+

Holdings

as of Oct 31, 2024

Sun Pharmaceutical Industries Limited

11.05%

Suven Pharmaceuticals Limited

10.82%

IPCA Laboratories Limited

8.12%

Cipla Limited

6.85%

Illumina Inc

5.38%

Globus Medical Inc

5.30%

Alembic Pharmaceuticals Limited

5.12%

Small Cap

43.00%

Large Cap

22.70%

Mid Cap

18.90%

Uncategorized

15.20%

Pharmaceuticals & Biotechnology

71.50%

Healthcare Services

17.90%

Healthcare Equipment & Supplies

8.00%

Insurance

1.50%

Retailing

0.40%

Rolling Returns

Bars show distribution of returns in given range for selected time period.

View performance details

Things to know before you invest

add remove

What is in DSP Healthcare Fund?

  1. This thematic fund invests in established & upcoming companies in the pharmaceutical & healthcare space in India and internationally (primarily, the United States).
  2. It can have up to 25% allocation to global stocks to provide access to sectors less developed or available in India.
  3. It considers companies that 'help people get well soon' across the healthcare spectrum- including pharmaceuticals, hospitals, diagnostics etc.
  1. Offers the potential to grow your wealth & 'earn big' returns if this theme does well (a high-risk, high-return strategy).
  2. Favourable sector dynamics- Rising income levels, increasing health-consciousness, government policies means an increase in healthcare spending, so companies in this space could do well.
  3. The up to 25% international exposure with low correlation to Indian healthcare companies means healthy diversification.
  4. Can help you beat the impact of rising prices over the long-term.
  5. Can be a suitable choice for tactical allocation.
  1. Consider this fund if you
    • Are an experienced investor with a well-set core portfolio & know what you're doing.
    • Are looking to tactically allocate 10-15% of your overall portfolio to very high-risk opportunities.
    • Understand that there is very high risk involved in this category of funds in the quest for high returns.
    • Have the patience and sectoral understanding to 'extract value' from changing sector cycles.
  1. This is a sectoral/ thematic fund, therefore its NAV is likely to fluctuate a lot more than diversified equity funds.
  2. Please do not use recent or past returns as the only criteria to evaluate this fund.
  3. This fund carries Very High Risk.

Fund managers:

Chirag Dagli

Chirag Dagli

Total work experience of 23 years. Managing this fund since December 2020
Total work experience of 23 years. Managing this fund since December 2020

arrow_forwardSee funds managed by him

arrow_forwardSee his investing philosophy

Portfolio

Prescribed asset allocation: 80% - 100% Equity and equity related securities of pharmaceutical and healthcare companies , 0% - 20% Equity and Equity related securities of other Companies , 0% - 20% Debt, securitized debt and Money Market Securities , 0% - 10% Units of REITs & InvITs

Current Allocation

as of Oct 31, 2024

Top holdings

Sun Pharmaceutical Industries Limited

11.05%

Suven Pharmaceuticals Limited

10.82%

IPCA Laboratories Limited

8.12%

Cipla Limited

6.85%

Illumina Inc

5.38%

Allocation by Market Cap

Small Cap

43.00%

Large Cap

22.70%

Mid Cap

18.90%

Uncategorized

15.20%

Top Sectors

Pharmaceuticals & Biotechnology

69.50%

Healthcare Services

17.38%

Healthcare Equipment & Supplies

7.83%

Insurance

1.47%

Mutual-funds

0.68%

Top holdings

No Data to display

Top holdings

TREPS / Reverse Repo Investments

1.83%

Cash & cash equivalents

0.90%

Credit rating profile

Cash & Equivalent

98.40%

Instrument break-up

TREPS

100.00%


Indicators

Portfolio turnover ratio

0.15 last 12 months

Standard Deviation

15.77 %

Sharpe Ratio

0.87

Beta

0.93

R-Squared

91.44 %

Compare Performance

Performance highlights over last

for

investment

Cumulative returns on

Annual returns

Current value

Min CAGR:
MedianCAGR:
Max CAGR:

Good Returns

return card icon

Negative Returns

return card icon

vs Category

return card icon

vs Benchmark

return card icon

  • Historical Returns (As per SEBI format)as of with investment of10,000

This fund BSE HEALTHCARE (TRI) ^ NIFTY 50 TRI #
CAGR Current Value CAGR Current Value CAGR Current Value

Income distribution Cum Capital Withdrawal (IDCW) Distributed

Record Date IDCW per unit NAV Before NAV After

Chart type

Invested as

Invested Amount

Invested since

This fund

Vs

BSE HEALTHCARE (TRI)

NIFTY 50 TRI

Gold

PPF

Funds Annual returns Current Value Absolute Growth

Chart type:

Invested as

Invested Amount

Invested period

Funds Minimum Median Maximum % times -ve returns % times returns > 7%

Date of allotment: Nov 30, 2018.

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of Regular Plan.

Since inception returns have been calculated from the date of allotment till June 30, 2021

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Rolling returns have been calculated based on returns from regular plan growth option.

^ Fund Benchmark # Additional Benchmark

Fund Details

Fund Details

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
There is no assurance that the investment objective of the Scheme will be realized

Fund Type

Equity – Sectoral/Thematic
Pharma

An open ended equity scheme investing in healthcare and pharmaceutical sector

Riskometer

Level of Risk in the fund

View details
Riskometer

Minimum Investment

Rs.  100 Lumpsum
Rs.  100 SIP– 12 instalments
Rs.  100 Minimum Additional Purchase

FAQs

FAQs

The DSP Healthcare Fund is a Sectoral/thematic mutual fund scheme that invests in companies within the healthcare theme. This healthcare theme includes industries such as pharmaceuticals, biotechnology, medical devices, healthcare services, and more.. To invest in the DSP Healthcare Fund, Click on the INVEST button on the webpage (Click here). If you are an existing DSP Mutual Fund investor, you can start investing immediately. If you are new to DSP Mutual Fund, you will need to create a portfolio by filling out the necessary details If you are new to mutual funds, you will have to comply with and fulfil the KYC requirements. You can also invest in DSP Healthcare Fund through your mutual fund distributor.

Returns of the DSP Healthcare Fund depend on market conditions, sector performance, the performance of individual companies in the underlying portfolio, the investment horizon, and other factors. Sectors within the healthcare theme, such as pharmaceuticals, are considered conservative. Historical trends from developed markets like the US show that medical costs rise with growth in per capita income (Source: American Medical Association) Since India's per capita income is expected to grow significantly in the coming decades, the long-term outlook for the healthcare theme is promising (Source: Deloitte).

Investors can check the past performance of the DSP Healthcare Fund by clicking on the (performance) section. You can view both lump-sum and SIP returns. We have displayed how the DSP Healthcare Fund has performed versus its benchmark index (BSE Healthcare TRI) and its additional benchmark (NIFTY 50 TRI) over the last 1, 3, and 5 years, as well as since its inception. Equity fund performance should always be evaluated over long investment periods.

The expense ratio is the percentage of the fund's assets used to cover expenses like administration, management, marketing, etc. Essentially, it is a percentage of your investment that goes toward the fund?s operating expenses and management fees. The expense ratio of the DSP Healthcare Fund can be seen on the TER page

Most mutual funds have two plans: direct and regular. In the case of the DSP Healthcare Fund, the expense ratio is higher for its regular plan and lower for its direct plan. Direct plans have a lower expense ratio, whereas regular plans have a higher expense ratio. Regular plans have a higher expense ratio because they are distributed/sold through an intermediary, i.e., a mutual fund distributor. A higher expense ratio for regular plans ensures that the mutual fund distributor also receives compensation for distributing/selling the mutual fund scheme.

  • Since Healthcare is a moderately conservative theme it can possibly produce more consistent returns across investment cycles compared to cyclical industries.
  • Healthcare is also a structural theme due to rising per capita income, increasing insurance penetration, growing government expenditure, and rising FDIs in healthcare (Source: National Institutes of Health). As our economy grows, the healthcare theme has the potential to create wealth for investors over a long investment horizon.
  • Historical data shows that the healthcare index is less volatile than broad-based indices like the Sensex (Source: NSE)
  • Even though the DSP Healthcare Fund is a thematic fund, it is diversified across multiple sectors like pharmaceuticals, hospitals, diagnostic centres, global medical equipment, health insurance, etc.
  • Up to 25% international exposure not only provides richer diversification (low correlation to Indian healthcare companies), it also provides exposure investment opportunities in advanced areas of life sciences which are relatively less developed in India e.g. robotic surgery, genetic technology, gene sequencing etc.

Healthcare funds are equity-oriented schemes, and the risk profile of these investments is higher than traditional fixed-income investments; there is no guarantee of capital safety or assured returns in equity funds. Furthermore, being thematic funds, healthcare funds invest in just healthcare sectors and sub industries within the sector compared to diversified equity funds implying higher risk. Investors should consider other risk factors like regulatory risks (both local and foreign), clinical trial risks, geopolitical factors, technological disruptions etc. The healthcare sector is known for stability and resilience of earnings, as demand for healthcare services remains relatively consistent, investors should be aware of the risk factors and make informed investment decisions. Investors are advised to consult their financial advisors or mutual fund distributors to understand whether the DSP Healthcare Fund is suitable for their long-term investment needs.

team 1.7 lakh peoplehave invested in this fund as of